HeyJaredPriyanka Sharma
- Indexed articles, last 90 days
- 66
- Latest publication
- Sep 25, 2026
- Outlet visibility, for Livemint
- Top 10K sites
- Earliest in this view
- Jul 5, 2026
Latest articles
Regulator mulls digital platform for drugmakers' test reports | Today News (opens the original)
Read excerpt
New Delhi: In a push for higher safety and transparency, India’s drug regulator is looking to bring pharmaceutical quality checks into public view. In a first, it plans to create a digital platform where consumers can access batch-level quality-test reports of medicines released for sale by drugmakers, according to two officials and a Rajasthan government communication to the Central Drugs Standard Control Organisation (CDSCO). The move would go beyond the current practice of only flagging drugs
Mint Explainer | Why NHRC wants India’s drugs regulator to build a national digital registry | Mint (opens the original)
Read excerpt
This is a Mint Premium article gifted to you.Subscribe to enjoy similar stories. The National Human Rights Commission (NHRC) wants India’s drug regulator to build a centralized digital registry for medicines to curb counterfeit drugs. The rights panel has proposed a centrally regulated authentication system using dynamic, uniquely serialized QR codes, along with a national database to track medicines through the supply chain. It has also called for stronger enforcement, including faster judicial
India mulls a wholesale-retail pharmacy ratio to curb misuse | Today News (opens the original)
Read excerpt
This is a Mint Premium article gifted to you.Subscribe to enjoy similar stories. New Delhi: The Centre plans to review how retail and wholesale drug licences are issued and, for the first time, is mulling an indicative ratio based on factors such as population, disease burden and existing licence density, according to two government officials and documents reviewed by Mint. The move could bring greater uniformity in drug licensing across states and curb misuse of wholesale licences for retail sa
Centre moves to review surgical consumable prices after Mundhe push | Mint (opens the original)
Read excerpt
This is a Mint Premium article gifted to you.Subscribe to enjoy similar stories. The Centre has begun consultations with private hospitals on billing practices and the pricing of surgical consumables, after Maharashtra Food and Drugs Administration (FDA) Commissioner Tukaram Mundhe called for a national review of wide gaps between hospitals’ procurement costs and the maximum retail prices (MRPs) charged to patients, according to two people familiar with the matter. The Department of Pharmaceutic
FSSAI initiates legal action against Nestlé India over alleged infant food violations | Company Business News (opens the original)
Read excerpt
New Delhi: The Food Safety and Standards Authority of India (FSSAI) has initiated legal action against Nestlé India Ltd in three cases involving alleged promotional violations and nutritional non-compliance in its infant food portfolio, the top food regulator said in an Instagram post on Friday. Nestle India said it remains compliant with all applicable regulations in the country. The legal proceedings involve promotional claims made for two infant formula brands, NAN Excella Pro Stage 1 and Lac
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 10K sites
For Livemint, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.